Plain-English translation of NCT07614594 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are testing whether special urine tests can reliably detect urothelial carcinoma—a cancer of the bladder and upper urinary tract—without invasive procedures. The study compares different urine-based approaches (including genetic analysis and DNA patterns) to see which ones work best at identifying cancer in patients who already have signs of a possible lesion on imaging.
Currently, diagnosing this type of cancer requires invasive procedures like cystoscopy and tissue biopsies. This trial aims to develop a simple, non-invasive urine test that could detect cancer earlier and spare patients from more uncomfortable diagnostic procedures.
You likely qualify if…
You likely don't qualify if…
You will provide urine samples that researchers will test using various genetic and molecular methods. Since this is an observational study, you are not receiving any new treatment—the researchers are simply analyzing your urine alongside your standard cancer diagnostic workup (cystoscopy and/or biopsy). Your participation helps validate whether these non-invasive urine tests can accurately identify cancer.
AI-generated summary from trial data · Jul 4, 2026 · Not medical advice
China
Enrollment target
~800 participants
Started
October 2019
Primary completion
December 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in July 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Kunpeng Shu
Henan Provincial People's Hospital
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.